Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Feb 10, 2009


Dan Clutter has become vice president of commercial development at Gentel Biosciences. Prior to joining the company, he held sales, marketing, and business development positions at PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand, and NimbleGen.

Eric Winzer has joined the board of directors of Cytomedix, where he will also serve as audit committee chairman and audit committee financial expert. He is the executive vice president and chief financial officer of Avalon Pharmaceuticals. Prior to joining Avalon, he was senior vice president and chief financial officer of Invitrogen. Winzer holds an MBA from Mount Saint Mary’s University and a BA in economics and business administration from McDaniel College.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.